Teriflunomide Accord Európai Unió - magyar - EMA (European Medicines Agency)

teriflunomide accord

accord healthcare s.l.u. - teriflunomide - a sclerosis multiplex, a relapszáló-remittáló - immunszuppresszánsok, szelektív immunszuppresszánsok - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).